Australia and New Zealand Radiotherapy Market Size And Forecast
According to Verified Market Research, the Australia Radiotherapy Market was valued at USD 547.3 Million in 2018 and is projected to reach USD 950.8 Million by 2026, growing at a CAGR of 7.34% from 2019 to 2026. However, the New Zealand Radiotherapy Market was valued at USD 73.2 Million in 2018 and is projected to reach USD 129.0 Million by 2026, growing at a CAGR of 7.48% from 2019 to 2026.

What is Radiotherapy?
Radiotherapy is an important and highly specialized treatment, supervised by a radiation oncologist, which uses radiation directed at a localized area to kill or damage the cancer cells. Radiotherapy is an important type of cancer treatment that can be given with the intention to cure or control cancer or it might even be given to relieve symptoms. Radiation therapy either can be used on its own or in conjunction with other treatments such as chemotherapy or surgery. Radiotherapy is usually given as one outpatient treatment or a series of outpatient treatments over a defined period, though under some circumstance’s patients may be treated as admitted patients.

Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=33410&utm_source=Free&utm_medium=004

Australia and New Zealand Radiotherapy Market Outlook
In the report, the market outlook section mainly encompasses the fundamental dynamics of the market which include drivers, restraints, opportunities, and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.

A few of the major factors driving the growth of the Radiotherapy market in Australia and New Zealand are the growing number of cancer patients, increasing adoption of radiotherapy devices and procedures, increasing the geriatric population and technological advancements in radiotherapy devices. However, the lack of skilled professionals for radiotherapy may hinder market growth.

Verified Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The “Australia and New Zealand Radiotherapy Market” is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.

Australia and New Zealand Radiotherapy Market, Segment Analysis
Australia and New Zealand Radiotherapy Market are segmented on the basis of End-User, Component, Type, and Country.

Australia and New Zealand Radiotherapy Market, by End-User:
On the basis of the End-User, the market is bifurcated into Hospitals & Clinics and Cancer Research Institutes. Australia and New Zealand Radiotherapy Market for Hospitals & Clinics segment are anticipated to be largest over the estimated period. Large multispecialty hospitals and hospital groups that work under government sponsorship or through private entities are the key end-users, which highly influences the market growth. These hospitals comprise more than 500 beds, and offer many inpatient and outpatient services, thereby generating more revenue. The sales of radiotherapy services in hospitals will increase with the increased number of individuals with cancer.

Australia and New Zealand Radiotherapy Market, by Component:
By Component, the market is classified into Hardware and Software. Australia and New Zealand Radiotherapy Market for Hardware segment are expected to be the largest as well as fastest-growing during the forecast period. The factor driving the growth of the segment is the increasing incidence of cancer supported by capital funding in the healthcare department. Advances in technology, growing focus on enhancing professional skills, and an increase in innovative business strategies are several factors to influence the growth during the forecast period.

Get More Information @ – https://www.verifiedmarketresearch.com/download-sample/?rid=33410&utm_source=Free&utm_medium=004

Australia and New Zealand Radiotherapy Market, by Type:
By Type, the market is classified into External Radiotherapy, Internal Radiotherapy, and Systemic Radiotherapy. Australia and New Zealand Radiotherapy Market for the External Radiotherapy segment are expected to be the largest as well as fastest-growing during the forecast period. This therapy is generally used in breast cancer treatment, bowel cancer treatment, head & neck cancer treatment, lung cancer treatment, brain tumor treatment, and others.

Australia and New Zealand Radiotherapy Market, Competitive Landscape
The Australia & New Zealand Radiotherapy Market is highly fragmented with the presence of a large number of players. Some of the major companies Genesis, NL-TEC Pty Ltd, Alphatech Systems Limited, Varian, Elekta, Sirtex, Noxopharm, Philips, Telix Pharmaceutical and Theranostics Australia.

Varian is one of the top five players for the Australia and New Zealand Radiotherapy market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Obtain Report Details @ https://www.verifiedmarketresearch.com/product/australia-and-new-zealand-radiotherapy-market/?utm_source=Free&utm_medium=004